Skip to content

SCHILD - protective intervention for longtime course in depression

SCHILD - protective intervention for longtime course in depression - SCHILD

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
DRKS
Registry ID
DRKS00006819
Enrollment
180
Registered
2014-10-31
Start date
2015-03-12
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

F32 F33

Interventions

Group 1: The intervention consists of four sessions, which will be conducted on a fortnightly basis, beginning after discharge from inpatient treatment. The psychoeducational part includes information

Sponsors

Universitätsklinikum Freiburg Klinik für Psychiatrie und Psychotherapie AG Psychotherapie und Versorgungsforschung
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: Patients: Primary treatment indication: Diagnosis of an acute depressive episode according to ICD-10 F32.xx or F33.xx; at least 18 years or older; a relative named by the patient is willing to participate in the study. Relatives: Nomination by the index-patient, who meets the inclusion criteria described above; at least 18 years or older; sufficient knowledge of the German language, to ensure that data can be gathered by questionnaire and that the contents of the psychoeducational group intervention can be understood; permanent habitation in the proximity of the particular study center (participating at the Intervention has to be feasible).

Exclusion criteria

Exclusion criteria: Patients with the following comorbidities: dementia (F00.xx, F01.xx, F02.xx, F03.xx); borderline personality disorder (F60.31); schizoaffective disorder (F25.xx); schizophrenia (F20.xx); bipolar disorder (F31.xx); substance disorder (F10.2, F11.2, F12.2, F13.2, F14.2, F15.2, F16.2, F17.2, F18.2, F19.2).

Design outcomes

Primary

MeasureTime frame
Estimated number of depression free days (DFD) within one year after discharge from inpatient depression treatment measured with the Patient Health Questionnaire (PHQ-9) at five time points (T0 = at discharge from inpatient treatment, T1 = 3, T2 = 6, T3 = 9 and T4 =12 months after discharge from inpatient treatment).

Secondary

MeasureTime frame
Patient-related: level of expressed emotion (German questionnaire on family atmosphere , FEF) T0, T2 & T4; perceived criticism of relative (Hooley & Teasdale, 1989)T0, T2 & T4; health care utilization (self-construction in accordance with the German Health Interview and Examination Survey for Adults (DEGS), a german questionnaire on resource utilization (Fragebogen zur Inanspruchnahme medizinischer und nicht-medizinischer Versorgungsleistungen im Alter, FIMA) and the Client Sociodemographic and Service Receipt Inventory (CSSRI-D)) T1 - T4; state of employment (DEGS, CSSRI-D) T1 - T4; days of inability to work (DEGS, CSSRI-D) T1 - T4; impairment of functional capability, activity and participation (WHO Disability Assessment Schedule, WHODAS 2.0) T0 - T4; adverse events (self-construction) T2 & T4. Relative-realated : problem solving competency (Social Problem-Solving Inventory-Revised, SPSI-R) T0, T2 & T4; level of expressed emotion (Family Questionnaire, FQ) T0, T2 & T4; psychological stress (Symptomcheckliste, SCL-K-9) T0 - T4; level of disease-related burden (Involvement Evaluation Questionnaire, IEQ-EU) T0 - T4; depression literacy (Depression Literacy Test, D-Lit and self-construction) T0 & T2; control attributions (Illness Perception Questionnaire for Schizophrenia, IPQS-R) T0, T2 & T4; adverse events (self-construction) T2 & T4; acceptance (self-construction) T2; subjective benefit (self-construction) T2; appliance of problemsolving (self-construction) T2. Incremental cost-effective-ratio: Cost-effectiveness investigation analyses of the intervention through cost-effectiveness analysis (CEA) based on the perspective of the health insurance funds and the society. Sources of these analyses are (1.) depression-free-days, (2.) prevented days of inability to work and (3.) prevented rehospitalisation. Mediator- and moderator-analysis: Analysis in what way the EE-level both on relative-level and on patient-level, the disease-related and psychosocial burden of

Countries

Germany

Contacts

Public ContactFabian Frank

Universitätsklinikum Freiburg Klinik für Psychiatrie und Psychotherapie AG Psychotherapie- und Versorgungsforschung

fabian.frank@uniklinik-freiburg.de0761/270-69870

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Mar 15, 2026